Top Movers and Shakers Shake Up the Market

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  29 Dec 2025
 

•   BNAI  
   
  0.00%
•   DAIC  
   
  0.00%
•   ECDA  
   
  0.00%
•   HIT  
   
  0.00%
•   MREO  
   
  0.00%

$BNAI is the headline-grabber today, surging over 108% after Brand Engagement Network finalized a Vendor Services Project Agreement to deliver a custom AI engagement solution for a top-10 global pharmaceutical company. Investor excitement around AI applications and the promise of recurring revenue from high-profile clients has fueled extraordinary trading volume, driving the stock sharply higher.

$SIDU has been on fire, climbing nearly 33% following news of a $16.2 million defense contract. This follows a wild month where the stock has already skyrocketed roughly 250%, and investors are attributing the rally to both government contracts and broader speculative interest in aerospace and defense startups. Unusual volume signals continued retail investor interest, making $SIDU a stock to watch closely for volatility-driven opportunities.

$WOK jumped 24% on news that WORK Medical Technology struck a one-year exclusive distribution deal in East China for its AI-powered blood analyzer. The partnership is expected to significantly boost revenue in a rapidly expanding market for AI diagnostic devices. Traders are responding positively to the combination of innovation, geographic expansion, and strategic partnerships, viewing $WOK as a compelling short-term mover.

$STI rallied 22% after Solidion Technology received a second grant from the U.S. Department of Energy to accelerate research into anti-corrosive additives for nuclear reactors. This government-backed validation provides both credibility and potential for accelerated product development, which is translating into investor optimism. Analysts see the grant as a signal that $STI could be a growth story in the energy tech sector.

$HIT continues its winning streak, up nearly 21% in its fifth consecutive gain. The rally appears driven by positive market sentiment and steady accumulation by investors who see potential in the technology and growth trajectory. The consistent upward movement has caught the attention of momentum traders looking for a continuation of the trend.

On the downside,
$RARE suffered a massive 42% drop after late-stage trials for a genetic bone disorder treatment failed. Analyst downgrades, including Baird cutting the price target to $47, and increased fear among retail investors drove the heavy selloff. The high volume and rapid decline illustrate the extreme market reaction to negative trial results, emphasizing the risk associated with biotech plays.

$MREO faced a catastrophic 88% drop, reflecting extreme investor pessimism. Heavy pre-market selling and widening short interest have pushed the stock sharply lower, leaving it deeply oversold. Traders are viewing $MREO as a cautionary tale in speculative biotech risk management, highlighting the potential for rapid downside moves when market sentiment turns.

$SOAR $DAIC and $ECDA also suffered notable declines, with $SOAR down 28% amid rising short interest, $DAIC dropping for the tenth consecutive session, and $ECDA retreating 40% despite expanding sales channels. In all cases, selling pressure and investor caution outweighed any positive operational developments, resulting in dramatic intraday losses.

View All Headlines